According to the Market Statsville Group (MSG), the Global Dual Channel Deep Brain Stimulation (DBS) Devices Market size was valued at USD 1,091.9 million in 2023 and is expected to grow from USD 1,257.2 million in 2024 to USD 3,307.4 million by 2033, by exhibiting a CAGR of 11.7% during the forecast period (2024-2033).
A high growth rate is estimated for the dual channel deep brain stimulation devices market, driven by neurological disorders, especially Parkinson's disease, essential tremor, dystonia, and others. These devices generate electrical impulses that aid in stimulating those areas where the implant is placed within the brain, offering relief with therapeutic benefits to patients who have become refractory to pharmaceutical treatment.
Other technological appliances, such as improved battery life and device precision, are also boosting this market. Another factor contributing to this is increased awareness among patients and clinicians about the advantages of DBS therapy. Advanced healthcare infrastructure and higher spending on health drive the North American and European regions, while rapid growth is shown in the Asia-Pacific region due to increasing investments in healthcare and a growing patient pool. Key market players emphasize strategic collaborations and product innovations to enhance their market position and meet the present demand for advanced DBS solutions.
The Dual Channel Deep Brain Stimulation (DBS) Devices segment relates to medical devices that modulate electrical impulses via two channels in different brain sections. These devices are primarily deployed in diseases of the nervous system, notably Parkinson's disease, essential tremor, and dystonia—one which confers huge therapeutic benefits from the devices for patients who previously failed to respond to conventional medications.
One of the major drivers for the demand for dual-channel deep brain stimulation devices is the rising number of cases of neurological disorders. The incidences of Parkinson's disease, essential tremor, and dystonia are multiplying, mainly in the aging population. These disorders progress, miserably diminishing the quality of life of patients with severe motor and non-motor symptoms, for which the pharmacological treatment options become ineffective over time and require advanced treatment modalities. In contrast, DBS devices depend on constant electrical stimulation of the involved brain area to suppress such symptoms and regain enhanced functional capability in patients. When this ever-growing patient pool is coupled with the efficacy limitations brought about by traditional therapies, the result generally favors the adoption of DBS devices as a workable treatment solution. Advanced medical devices are, therefore, finding an expanding market since healthcare providers move to meet the emerging demands for innovative and effective neurological interventions.
The high cost of these dual-channel DBS devices and implantation procedures is quite discouraging, especially for low-income countries. Advanced medical devices naturally command substantial price tags, not only for the advanced hardware per se but also for highly specialized surgical procedures to implant them. This includes pre-surgical evaluation, actual surgery, after-surgery care, and regular follow-up visits for adjustments in the device. Most health systems in low-income and developing regions might lack the financial muscle to subsidize such expensive treatments, making it difficult for patients to access DBS therapy. In addition, most patients from such regions are generally constrained by economic factors and, even when such high-cost treatments exist, find it harder to afford. This financial barrier blocks a good number of people from receiving working and life-enhancing neurological care, hence short-circuiting the full potential spread of DBS devices across the world.
The study categorizes the Dual Channel Deep Brain Stimulation (DBS) Devices market based on type, application, and end-user area at the regional and global levels.
Based on the application, the market is divided into Parkinson's Disease, Essential Tremor, Dystonia, and Others. The infotainment segment accounted for the largest market share in the global Dual Channel Deep Brain Stimulation (DBS) Devices market. The Parkinson's disease application segment dominated the Dual Channel Deep Brain Stimulation (DBS) Devices market due to the high prevalence across the world and the high therapeutic benefit provided by DBS therapy in symptomatic treatment. It is a neurological disorder wherein, over time, motor symptoms manifest, such as tremors, rigidity, and bradykinesia, conclusively impairing the patient's quality of life. Devices for deep brain stimulation effectively alleviate those motor symptoms by providing electrical impulses to targeted areas in the brain, thus reducing motor fluctuations and enhancing patient mobility and function. Extensive clinical research and long-term successful treatment outcomes of DBS in Parkinson's disease have been a factor in strengthening its wide adoption by healthcare practitioners and patients alike, further cementing Parkinson's disease for driving growth in the DBS devices market.
Based on the regions, the global market of Dual Channel Deep Brain Stimulation (DBS) Devices has been segmented across North America, Europe, the Middle East & Africa, South America, and Asia-Pacific. North America dominates the dual channel deep brain stimulation devices market due to the development of healthcare infrastructure and high expenditure on healthcare. Further, it holds a significant prevalence of neurological disorders, such as Parkinson's disease, essential tremor, and dystonia, which would propel demand for an effective treatment against such diseases. Besides this, it is highly penetrated with significant players, which would motivate them to innovate and develop DBS technologies without any stop.
Furthermore, regulatory bodies support good reimbursement policies and promote the growth of the market. Extensive research and development activity with clinical trials will ensure that cutting-edge solutions and improvements in DBS devices come to the market. Well-structured healthcare in this region will enable easy diffusion of these medical technologies, and North America is the leading market for DBS devices.
The competitive landscape of the global Dual Channel Deep Brain Stimulation (DBS) Devices market is such that prominent players are impelled to innovate and collaborate on strategic initiatives. Key companies in this segment have been heavily investing in the creation of advanced DBS technologies, geographical reach, and broadening their product offerings to fight for dominance in this fast-growing medical device space.
Major players in the global Dual Channel Deep Brain Stimulation (DBS) Devices market are:
Frequently Asked Questions
Want to Review Complete Market Research Report
Budget constraints? Get in touch with us for special pricing
Request for Special PricingCustomize this Report
Related Reports
Medical Cannabis Oil Market 2021: Industry Size, Regions, Emerging Trends, Growth Insights, Development Scenario, Opportunities, and Forecast By 2027
Mar 2024Novel Vaccine Delivery System Market 2021: Industry Size, Regions, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2027
Mar 2024Lysosomal Storage Disease Treatment Market 2021: Industry Size, Regions, Emerging Trends, Growth Insights, Development Scenario, Opportunities, and Forecast By 2027
Mar 2024Single-Use Bioprocessing Market 2022: Industry Size, Emerging Trends, Regions, Growth Insights, Opportunities, and Forecast By 2033
Mar 2024Liver Health Supplements Market 2021: Industry Size, Regions, Emerging Trends, Growth Insights, Development Scenario, Opportunities, and Forecast By 2027
Mar 2024